Published in:

01-12-2003 | Invited Commentary

Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: New aspects after the fall of the pyramid and the rise of new therapeutics

Authors: Daniel Aletaha, MD, Josef S. Smolen, MD

Published in: Current Rheumatology Reports | Issue 6/2003